These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7865979)

  • 1. Indomethacin treatment in amphotericin B induced nephrogenic diabetes insipidus.
    Höhler T; Teuber G; Wanitschke R; Meyer zum Büschenfeld KH
    Clin Investig; 1994 Oct; 72(10):769-71. PubMed ID: 7865979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphotericin B-induced partial nephrogenic diabetes insipidus in a child.
    Hopp L; Bernardi J; Reeves G
    Pediatr Nephrol; 2001 Jul; 16(7):594-7. PubMed ID: 11465810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible liposomal amphotericin B-induced nephrogenic diabetes insipidus.
    Canada TW; Weavind LM; Augustin KM
    Ann Pharmacother; 2003 Jan; 37(1):70-3. PubMed ID: 12503936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative mechanisms involved in chronic antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
    Moosavi SM; Karimi Z
    Acta Physiol Hung; 2014 Mar; 101(1):88-102. PubMed ID: 24631797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative mechanisms of acute antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
    Moosavi SM; Haghani M
    Can J Physiol Pharmacol; 2010 Dec; 88(12):1191-201. PubMed ID: 21164566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful use of liposomal amphotericin B in a case of amphotericin B-induced nephrogenic diabetes insipidus.
    Späth-Schwalbe E; Koschuth A; Dietzmann A; Schanz J; Possinger K
    Clin Infect Dis; 1999 Mar; 28(3):680-1. PubMed ID: 10194097
    [No Abstract]   [Full Text] [Related]  

  • 7. Altered expression of COX-1, COX-2, and mPGES in rats with nephrogenic and central diabetes insipidus.
    Kotnik P; Nielsen J; Kwon TH; Krzisnik C; Frøkiaer J; Nielsen S
    Am J Physiol Renal Physiol; 2005 May; 288(5):F1053-68. PubMed ID: 15644490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency treatment of lithium-induced diabetes insipidus with nonsteroidal anti-inflammatory drugs.
    Lam SS; Kjellstrand C
    Ren Fail; 1997 Jan; 19(1):183-8. PubMed ID: 9044466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrogenic diabetes insipidus induced by two amphotericin B liposomal formulations.
    Metzger NL; Varney Gill KL
    Pharmacotherapy; 2009 May; 29(5):613-20. PubMed ID: 19397468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to low dose indomethacin in two children with nephrogenic diabetes insipidus.
    Dayal D; Verma Attri S; Kumar Bhalla A; Kumar R
    Pediatr Endocrinol Diabetes Metab; 2015; 20(4):178-81. PubMed ID: 26615585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative therapeutic benefit of indomethacin, hydrochlorothiazide, and acetyl-salicylic acid in a patient with nephrogenic diabetes insipidus.
    Vierhapper H; Jörg J; Favre L; Vallotton MB; Waldhäusl W
    Acta Endocrinol (Copenh); 1984 Jul; 106(3):311-6. PubMed ID: 6588700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphotericin B-induced nephrogenic diabetes insipidus.
    Ishikawa SE
    Intern Med; 2005 May; 44(5):403. PubMed ID: 15942081
    [No Abstract]   [Full Text] [Related]  

  • 13. Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial.
    Fotso Soh J; Torres-Platas SG; Beaulieu S; Mantere O; Platt R; Mucsi I; Saury S; Renaud S; Levinson A; Andreazza AC; Mulsant BH; Müller D; Schaffer A; Dols A; Cervantes P; Low NC; Herrmann N; Christensen BM; Trepiccione F; Rajji T; Rej S
    BMC Psychiatry; 2018 Jul; 18(1):227. PubMed ID: 30012135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrogenic diabetes insipidus in a lethargic lithium-treated patient.
    Meinardi JR; Donders SH
    Neth J Med; 1997 Mar; 50(3):105-9. PubMed ID: 9121593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium-induced Nephrogenic Diabetes Insipidus with Efficacy of Desmopressin in Combination with Thiazide Diuretics and Non-steroidal Anti-inflammatory Drugs: A Case Report with a Review of the Literature.
    Jinnouchi T; Yoshimoto M; Ogino K; Oji T; Hayashi M
    Intern Med; 2024 May; 63(10):1399-1404. PubMed ID: 37779064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel.
    Kim GH; Lee JW; Oh YK; Chang HR; Joo KW; Na KY; Earm JH; Knepper MA; Han JS
    J Am Soc Nephrol; 2004 Nov; 15(11):2836-43. PubMed ID: 15504936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphotericin B-induced nephrogenic diabetes insipidus in a case of cryptococcemia.
    Fujita Y; Kasahara K; Uno K; Konishi M; Maeda K; Yoshimoto E; Murakawa K; Mikasa K; Amano I; Morii T; Kimura H
    Intern Med; 2005 May; 44(5):458-61. PubMed ID: 15942094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bendamustine-Induced Nephrogenic Diabetes Insipidus in a Patient With AL Amyloidosis.
    Uwumugambi NA; Sanchorawala V; Shelton AC; Stern L; Gordon CE
    Am J Kidney Dis; 2017 Feb; 69(2):317-319. PubMed ID: 27780577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium-induced nephrogenic diabetes insipidus.
    Stone KA
    J Am Board Fam Pract; 1999; 12(1):43-7. PubMed ID: 10050642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of sodium depletion in acute antidiuretic effect of bendroflumethiazide in rats with nephrogenic diabetes insipidus.
    Janjua NR; Jonassen TE; Langhoff S; Thomsen K; Christensen S
    J Pharmacol Exp Ther; 2001 Oct; 299(1):307-13. PubMed ID: 11561093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.